Comparison
Abducens Nerve Neoplasm C1263898 vs 16p13 11 Microdeletion Syndrome C4304596
Clinical comparison between Abducens Nerve Neoplasm and 16p13 11 Microdeletion Syndrome for differential diagnosis and treatment planning.
Abducens Nerve Neoplasm C1263898
A tumor of the 6th cranial nerve that controls eye movement. Can affect anyone. Treated with surgery or radiation.
16p13 11 Microdeletion Syndrome C4304596
A rare chromosomal deletion where a portion of chromosome 16 is missing. It may be associated with developmental delays, intellectual disability, and sometimes congenital anomalies. Management focuses on supportive care and addressing individual needs.
6 comparison axes
Onset
Abducens Nerve Neoplasm C1263898
Variable
16p13 11 Microdeletion Syndrome C4304596
0-null
Onset patterns differ
Severity
Abducens Nerve Neoplasm C1263898
severe
16p13 11 Microdeletion Syndrome C4304596
moderate
Different severity levels
Chronic
Abducens Nerve Neoplasm C1263898
Chronic
16p13 11 Microdeletion Syndrome C4304596
Chronic
Differing course
Communicable
Abducens Nerve Neoplasm C1263898
No
16p13 11 Microdeletion Syndrome C4304596
No
Different transmission
Body System
Abducens Nerve Neoplasm C1263898
neurologic
16p13 11 Microdeletion Syndrome C4304596
congenital
Same/different system
Category
Abducens Nerve Neoplasm C1263898
oncology
16p13 11 Microdeletion Syndrome C4304596
genetic
Different category
Bottom line
abducens-nerve-neoplasm-C1263898 and 16p13-11-microdeletion-syndrome-C4304596 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | Abducens Nerve Neoplasm C1263898 | 16p13 11 Microdeletion Syndrome C4304596 | Discriminating power |
|---|---|---|---|
| Eye movement | May impair abduction and cause horizontal double vision if the sixth nerve is affected. | An eye-movement deficit is not described as a defining feature. | High |
| Development | Developmental delay is not described as a core feature. | May involve developmental delay, intellectual disability, or congenital anomalies. | High |
| Onset | Onset is variable and may follow previously normal function. | Source onset data are incomplete; a congenital or early course is expected. | Moderate |
When to favor each condition
Choose Abducens Nerve Neoplasm C1263898 when
Progressive horizontal double vision with limited abduction
This pattern suggests sixth-nerve dysfunction and needs neurologic assessment.
Moderate
Imaging shows a mass along the abducens nerve
A neoplasm is considered when imaging and examination agree; histology confirms it.
High
Tumor-directed treatment is being planned
Source care includes surgery or radiation, chosen by specialists after diagnosis.
Moderate
Choose 16p13 11 Microdeletion Syndrome C4304596 when
Developmental delay with possible congenital anomalies
A chromosomal cause may be considered, but symptoms alone do not diagnose it.
Moderate
Testing identifies a 16p13.11 deletion
Laboratory confirmation with clinical correlation supports the genetic condition.
High
Supportive developmental care is the main need
Described management addresses individual needs rather than treating a nerve tumor.
Moderate
How key tests differ
| Test | Abducens Nerve Neoplasm C1263898 | 16p13 11 Microdeletion Syndrome C4304596 | Interpretation |
|---|---|---|---|
| MRI of brain and skull base | May show a lesion along the sixth-nerve pathway. | Does not establish a chromosomal deletion. | Imaging evaluates a suspected nerve lesion, not the genetic diagnosis. |
| Chromosomal microarray | Not a test for an abducens-nerve tumor. | May detect a 16p13.11 deletion. | A deletion result requires laboratory and clinician interpretation. |
| Neuro-ophthalmic examination | May document reduced abduction or diplopia. | No specific eye-movement result is established. | Examination localizes dysfunction but does not prove either diagnosis. |
Prognosis comparison
Abducens Nerve Neoplasm C1263898
- Outcome
- Course depends on tumor type, location, and treatment response; survival figures are not established.
- Factors
- Nerve involvement, confirmed histology, and treatment complications.
16p13 11 Microdeletion Syndrome C4304596
- Outcome
- Often chronic developmental needs with wide variation; mortality is not established.
- Factors
- Deletion findings, anomalies, developmental profile, and available supports.
Time frame: Either may be long-term, but onset and trajectory differ and require individual assessment.
This comparison cannot predict an individual outcome.
Complications comparison
| Complication | Presentation |
|---|---|
| Diplopia or misalignment | Possible from sixth-nerve dysfunction. Not established as characteristic. Functional impact depends on extent and requires clinical assessment. |
| Treatment-related effects | Surgery or radiation may have procedure-specific risks. Tumor-directed treatment is not the described approach. Risks, doses, and outcomes are not established here. |
| Learning and developmental needs | Not a core described feature. Delay, disability, or anomalies may occur. Needs vary widely; an exact course is not established. |
Patient education highlights
- HighDifferent conditions
A nerve tumor and chromosomal deletion have different causes, tests, and care pathways.
- HighUrgent symptoms
Sudden visual change, severe headache, weakness, or rapidly worsening double vision needs prompt assessment.
- MediumConfirmation
Examination, imaging, or genetic results must be interpreted by clinicians and are not diagnoses by themselves.